BLOG

Stem Cell Therapy and Standard Care: Questions to Ask in Osaka

Published 2026.10.21 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Many international patients who learn about regenerative medicine in Japan ask the same practical question: where does adipose-derived stem cell therapy fit alongside the care I already receive? It is a sensible question. Stem cell therapy is often discussed online as if it were a stand-alone solution, yet in real clinical practice it is only one option among many, and it is best considered together with your existing medical care. This article explains the general relationship between the two, and offers questions you can bring to your own doctors and to Grand Green Osaka Umekita Clinic.

The short answer: it is an option to discuss, not a replacement

Adipose-derived stem cell therapy is a regenerative treatment in which mesenchymal stem cells taken from your own fat tissue are cultured, expanded, and returned to your body by intravenous infusion. It is provided in Japan as a self-pay (non-insured) treatment. It should not be understood as a cure for any disease, and it should not be seen as a substitute for treatment recommended by your primary physician or specialist.

Whether it is appropriate for you depends on your condition, your history, your current treatments, and the judgment of a physician who has examined you. For that reason, the most useful first step is not to decide in advance, but to gather information and discuss it openly with the doctors involved in your care.

What the research does and does not tell us

Mesenchymal stem cells have been studied worldwide, and published research has reported that they can secrete anti-inflammatory substances and growth factors that may support the repair of damaged tissue. Clinical studies have looked at applications such as osteoarthritis, and some have reported encouraging signals. At the same time, study designs, cell preparations, doses, and patient groups differ widely, and results are not uniform.

This is why a single study, a news story, or a personal account should never be treated as proof that a treatment will work for you. A responsible approach is to look at public sources such as PubMed, to read reviews that compare multiple studies, and to ask your doctor how the available evidence applies to your specific situation. Evidence is still developing, and a careful physician will be open about what remains uncertain.

Why your existing care still matters

Standard care, such as medication, rehabilitation, lifestyle guidance, and procedures recommended by your specialist, is generally supported by established guidelines and long clinical experience. Stem cell therapy does not remove the need for that foundation. If you are already under treatment, stopping or changing it without medical advice can carry real risks.

For international patients, this also raises a practical point about continuity. After you return home, your regular doctor will remain the person who follows your health over time. Sharing your plans with that doctor, and bringing back information about any treatment you receive in Japan, helps keep your care coordinated and safe.

Questions to bring to your doctors

A short list of questions can make a consultation more productive. Consider raising the following with your home physician and again at your consultation in Osaka:

What are the standard treatment options for my condition, and have I already tried them?
Is there any reason my medical history, medications, or other conditions would make this treatment unsuitable?
What benefits have been reported in studies, and how certain is the evidence?
What risks and side effects should I be aware of, including those related to fat collection and infusion?
How will my existing treatments and follow-up be handled if I proceed?
What are the fees, the number of visits, and the overall schedule, and what is not included?

Because this treatment is self-pay, it is reasonable to confirm costs in writing before making any decision. Fees, risks, side effects, and suitability must all be confirmed through a physician’s examination rather than assumed from general information.

How Japan’s regenerative medicine framework fits in

In Japan, regenerative medicine of this kind is provided under the Act on the Safety of Regenerative Medicine, which requires providers to submit a treatment provision plan and to manage cell processing and safety in accordance with the law. This framework is designed to support oversight, but it does not guarantee any particular result. It is still important to ask the clinic how the treatment is positioned, how your cells are handled, and what information will be shared with you before you give consent.

If you are traveling from abroad, also think about practical matters such as how long you can stay, how language support will work during your consultation, and whether you will be able to attend any follow-up that your doctor advises. These details are best discussed early, so that you are not rushed.

Considering a consultation at Grand Green Osaka Umekita Clinic

Grand Green Osaka Umekita Clinic, located in the Umeda area of Osaka, offers adipose-derived stem cell therapy as a self-pay regenerative treatment, and provides an information page for international patients. If you are considering a visit, you may find it helpful to prepare your medical records, a list of your current medications, and your questions in advance.

A consultation is a chance to learn, not an obligation to proceed. A physician will review your situation, explain the treatment flow, fees, risks, and side effects, and help you judge whether this option is appropriate alongside your existing care. Taking time to compare your options, and to seek a second opinion if you wish, is a perfectly reasonable part of the process.

In summary, adipose-derived stem cell therapy is best viewed as one possible option to discuss with your doctors, not as a replacement for standard care. Approaching it with good questions, realistic expectations, and a coordinated care plan will help you make a decision that fits your own circumstances.

Stem Cell Therapy and Your Care

Not a replacementOne option beside standard care
Check the evidence
Doctor's exam first
Plan follow-up

This figure is a conceptual summary of the article's content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›